Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: OGLUO
Active substances:
Estonian, English, Latin
ATC code: H04AA01
Dosage form: solution for injection in pre-filled pen
Strength: 0,5mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: Ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
Safety features: Yes
Marketing authorization holder: Tetris Pharma B.V. 
Marketing authorization number: EU/1/20/1523 
Marketing authorization issued on: 11 February 2021 
Marketing authorization expires on: 17 February 2026 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1841813  OGLUO  solution for injection in pre-filled pen  0,5mg 1TK  Prescription           
1841824  OGLUO  solution for injection in pre-filled pen  0,5mg 2TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription